GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML

glucagon injection, solution
$3205.3200per ML

Strength

.5 mg/.1mL

NDC

72065012012

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

2/1/2026

Active Ingredients

GLUCAGON

Approval Type

New Drug (NDA)

FDA Application

NDA212097

On Market Since

9/10/2019

Pharmacological Classes

Antihypoglycemic Agent
Decreased GI Motility
Decreased GI Smooth Muscle Tone
Decreased Glycolysis
Gastrointestinal Motility Inhibitor
Increased Gluconeogenesis
Increased Glycogenolysis

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.1%

1Y

+2.9%

3Y

+9.1%

5Y

N/A

All

+15.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.